VEGFA and neoplasm: In addition to prompt angiogenesis, VEGF attenuates anti-tumor response by negatively affecting antigen-presenting cells (APCs) and effector T cells while maintains immunotolerant TME by positively increasing MDSCs and Tregs recruitment (125).